Drugs / AST-VAC2
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03371485 | May 2018 → Aug 2022 | non-small cell lung carcinoma | Cancer Research UK | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AST-VAC2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03371485 ↗ |
| Modality | Vaccine | “This clinical study is looking at a vaccine called AST-VAC2.” NCT03371485 ↗ |
| Target | TERT | “AST-VAC2 will target the hTERT protein.” NCT03371485 ↗ |